SCHEMBL6448868

SCHEMBL6448868

O=C(NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)c1ccncc1)c1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.56
RPS6KA5 O75582 2/20 0.56
PRKACA P17612 2/20 0.56
MAPK1 P28482 2/20 0.56
GSK3A P49840 2/20 0.56
GSK3B P49841 2/20 0.56
PRKX P51817 2/20 0.56
ROCK1 Q13464 2/20 0.56
PRKG1 Q13976 2/20 0.56
PKN2 Q16513 2/20 0.56
CLK4 Q9HAZ1 2/20 0.56
SGK2 Q9HBY8 2/20 0.56
RPS6KA4 O75676 1/20 0.56
IRAK1 P51617 1/20 0.56
RAB9A P51151 1/20 0.52
TDP1 Q9NUW8 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
CTRB1 P17538 5/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931878 0.89 CTRB1 (0.59) RAB9ACTRB1
SCHEMBL6444614 0.85 ECE1 (0.67) RAB9AGAAKDM4ECYP3A4CYP2C19
SCHEMBL7277346 0.84 CA2 (0.56) ROCK2RPS6KA5PRKACAMAPK1GSK3A
SCHEMBL23304046 0.81 PTPN1 (0.66) ROCK2RPS6KA5PRKACAMAPK1GSK3A
SCHEMBL23304049 0.81 PTPN1 (0.66) ROCK2RPS6KA5PRKACAMAPK1GSK3A
SCHEMBL7277767 0.78 PSMB5 (0.55) TDP1MAPTKDM4EHTTEPHX2
SCHEMBL30341613 0.78 ROCK2 (0.66) ROCK2RPS6KA5PRKACAMAPK1GSK3A
SCHEMBL12320657 0.78 HPGDS (0.64) ROCK2RPS6KA5PRKACAMAPK1GSK3A
SCHEMBL6931268 0.77 HPGDS (0.58) CTRB1KDM4E
SCHEMBL6929399 0.77 HPGDS (0.48) RAB9ACTRB1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed